Advertisement

Topics

Search Results for "Cvs Minute Clinic Shingles Vaccine"

16:52 EDT 24th September 2016 | BioPortfolio

Matching Channels

Varicella

Varicella zoster virus (VZV) is one of eight herpes viruses known to infect humans (and other vertebrates). Varicella-zoster virus is known by many names, including: chickenpox virus, varicella viru...

HPV vaccine

Rotavirus Vaccine GSK

Smallpox Vaccine MVA

Poliovirus Vaccine OPV

Matching News

New Shingles Vaccine May Have Higher Efficacy in Older Adults – Medscape

MedscapeNew Shingles Vaccine May Have Higher Efficacy in Older AdultsMedscapeA new two-dose herpes zoster vaccine called HZ/su is safe and reduces the risk for shingles and postherpetic neuralgia by n...

GSK’s candidate shingles vaccine shows high efficacy against shingles

GSK has announced the publication of detailed results from a randomized phase III study (ZOE-70) of its investigational shingles vaccine, Shingrix, showing 90% efficacy in adults aged 70 years and old...

Experimental Shingles Vaccine Looks Quite Effective: Study

WEDNESDAY, Sept. 14, 2016 -- An experimental vaccine against shingles may offer lasting protection for most older adults who receive it, a new clinical trial found. Shingles is a painful rash that's t...

New Shingles Vaccine May Have Higher Efficacy in Older Adults

Phase 3 clinical trial data showed the new shingles vaccine HZ/su is safe and greatly reduces the risk for shingles and postherpetic neuralgia in people 70 years and older. Medscape Medical News

GSK’s Candidate Shingles Vaccine Shows High Efficacy Against Shingles and its Complications in Adults Aged 70 Years and Over

14 September 2016 -- GSK (LSE/NYSE: GSK) today announced the publication of detailed results from a randomised phase III study (ZOE-70) of its investigational shingles vaccine, Shingrix, showing 90% e...

GSK's Shingles Vaccine Shows High Efficacy in Phase 3 Study

NewsGSK's candidate shingles vaccine shows high efficacy against shingles and its complications in adults aged 70 years and over in phase III study published in NEJM.

GSK’s shingles vaccine tops MSD rival in Ph III testing

GlaxoSmithKline’s shingles vaccine Shingrix has topped rival MSD treatment Zostavax as it is shown to remain effective in elderly patients after four years, according to a recent Phase III study pub...

Ontario provides shingles vaccine to its senior citizens for free

The Canadian province of Ontario is providing the shingles vaccine free of charge to 850,000 people aged between 65 and 70 years old, as part of its publicly funded immunisation programme.

Matching PubMed Articles

The immunogenicity and safety of a tetravalent measles-mumps-rubella-varicella vaccine when co-administered with conjugated meningococcal C vaccine to healthy children: A phase IIIb, randomized, multi-center study in Italy.

Multiple vaccination visits and administrations can be stressful for infants, parents and healthcare providers. Multivalent combination vaccines can deliver the required number of antigens in fewer in...

Herpes Zoster Vaccine in the Long-Term Care Setting: A Clinical and Logistical Conundrum.

Advancing age is associated with an increased risk of herpes zoster (shingles) infection and latent effects such as postherpetic neuralgia. The herpes zoster vaccine is recommended in those 60 years o...

Influenza vaccine effectiveness: Maintained protection throughout the duration of influenza seasons 2010-2011 through 2013-2014.

Factors, such as age, comorbidities, vaccine type, herd immunity, previous influenza exposure, and antigenic shift, may impact the immune response to the influenza vaccine, protection against circulat...

Herpes zoster and the search for an effective vaccine.

Primary infection with Varicella Zoster Virus (VZV), an exclusively human neurotropic alphaherpsesvirus, results in varicella, more commonly known as chickenpox. Like other alphaherpesviruses, VZV est...

Rapid Screening for Cognitive Impairment in Parkinson's Disease: A Pilot Study.

Aim. This study sought to establish the discriminant validity of a rapid cognitive screen, that is, the National Institute of Neurological Disease and Stroke-Canadian Stroke Network (NINDS-CSN) 5-minu...

Search Whole site using Google

Loading
Quick Search
Advertisement
 
Advertisement Advertisement